NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog

Manufacturer of innovative dialysis products, NxStage Medical Inc. (NXTM), reported adjusted loss of 8 cents per share in the fourth quarter of 2014, narrower than the Zacks Consensus Estimate of loss by a couple of cents



from Content Keyword RSS http://ift.tt/18ORihf

via IFTTT